Oral insulin (Generex Biotechnology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOral insulin (Generex Biotechnology)
Drug Alias NameOral RecosulinInsulin buccalOral-lynOralinOralgen +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonistsOrnithine decarboxylase stimulants
TargetsInsulin receptorOrnithine decarboxylase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEcuador
Original Approved Date2005/01/01
Country/TerritoryEcuador
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGenerex Biotechnology Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A